wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42422372-6AF7FD2B-8BED-42CA-B1B4-C83B3F2EA4C1
Q42422372-6AF7FD2B-8BED-42CA-B1B4-C83B3F2EA4C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42422372-6AF7FD2B-8BED-42CA-B1B4-C83B3F2EA4C1
Lucinactant: new and approved, but is it an improvement?
P2860
Q42422372-6AF7FD2B-8BED-42CA-B1B4-C83B3F2EA4C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42422372-6AF7FD2B-8BED-42CA-B1B4-C83B3F2EA4C1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4f842d77f63edecae8babf0d80df344c62e696ac
P2860
A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.